About Cilia- and flagella-associated protein 36
Cilia- and flagella-associated protein 36 (CFAP36) is a protein
from Homo sapiens identified by UniProt accession
Q96G28, 342 residues long.
MolForge cross-references it against 0 known binders and
29 disease associations.
Target properties
| Protein name | Cilia- and flagella-associated protein 36 |
| UniProt accession | Q96G28 |
| Gene | CFAP36 |
| Organism | Homo sapiens |
| Length | 342 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (29)
Diseases linked to this target (Open Targets).
- systolic blood pressure · score 0.31
- cortical thickness · score 0.12
- body height · score 0.11
- hypothyroidism · score 0.08
- Antiglaucoma preparations and miotics use measurement · score 0.07
- metabolite measurement · score 0.07
- isolated asymptomatic elevation of creatine phosphokinase · score 0.07
- autoimmune thyroid disease · score 0.06
- Vitiligo · score 0.06
- Thyroid preparation use measurement · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96G28-F1 | alphafold | PREDICTED | 73.00 | — |
Amino-acid sequence (342 residues)
MAAEEEDEVE WVVESIAGFL RGPDWSIPIL DFVEQKCEVF DDEEESKLTY TEIHQEYKEL VEKLLEGYLK EIGINEDQFQ EACTSPLAKT HTSQAILQPV LAAEDFTIFK AMMVQKNIEM QLQAIRIIQE RNGVLPDCLT DGSDVVSDLE HEEMKILREV LRKSKEEYDQ EEERKRKKQL SEAKTEEPTV HSSEAAIMNN SQGDGEHFAH PPSEVKMHFA NQSIEPLGRK VERSETSSLP QKDLKIPGLE HASIEGPIAN LSVLGTEELR QREHYLKQKR DKLMSMRKDM RTKQIQNMEQ KGKPTGEVEE MTEKPEMTAE EKQTLLKRRL LAEKLKEEVI NK
Explore Cilia- and flagella-associated protein 36 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets